Cargando…
Rapid desensitization for brentuximab vedotin (Adceteris(®)) allergy: a case report
BACKGROUND: Brentuximab vedotin (BV) is an antibody–drug conjugate formed by an anti-CD30 chimeric IgG(1) conjugated with monomethyl-auristatin-E. BV targets the CD30(+) cells, which characterize Hodgkin lymphoma as well as anaplastic large cell lymphoma. Once bound to the CD30(+) cells BV exerts it...
Autores principales: | Di Girolamo, Attilio, Albanesi, Marcello, Sinisi, Alessandro, Nettis, Eustachio, Di Bona, Danilo, Caiaffa, Maria Filomena, Macchia, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205792/ https://www.ncbi.nlm.nih.gov/pubmed/30386181 http://dx.doi.org/10.1186/s12948-018-0100-0 |
Ejemplares similares
-
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management
por: Magistà, Stefania, et al.
Publicado: (2020) -
A desensitization protocol for delayed allergy to cytarabine: analysis of two cases
por: Albanesi, Marcello, et al.
Publicado: (2018) -
Delayed allergy to acyclovir revealed by lymphocyte proliferation test
por: Albanesi, Marcello, et al.
Publicado: (2018) -
Immunological characterization of onion (Allium cepa) allergy
por: Albanesi, Marcello, et al.
Publicado: (2019) -
Chronic urticaria reveals JAK2V617F positive essential thrombocythemia
por: Albanesi, Marcello, et al.
Publicado: (2021)